DoD FY25 Melanoma Research Program Idea Award
Supports innovative, exploratory, high-risk/high-reward melanoma research that establishes proof of principle and generates preliminary data across prevention, rare subtypes, or survivorship focus areas.
Eligibility Criteria:
-
Organizations: Extramural and intramural U.S. or foreign academic institutions, biotechnology companies, foundations, DOD laboratories, and other public or private entities (for-profit and non-profit).
-
Principal Investigator: Must be at or above the level of Postdoctoral Fellow (or equivalent) by award activation; no citizenship restrictions.
-
Research Scope: Novel, hypothesis-driven or hypothesis-generating projects in at least one FY25 MRP focus area (Prevention & Interception; Rare Melanomas; Survivorship). Clinical trials are not permitted; observational clinical research allowed.
-
Cost Sharing: Not required.
Funding Details:
-
Total Cost Cap: 560,000 USD (direct + indirect)
-
Period of Performance: Up to 2 years; funds expire September 30, 2031; awards made by September 30, 2026.
-
Allowable Costs: Personnel; supplies; equipment; travel for multi-institutional collaborations and one scientific meeting per year. No clinical-trial costs.
Deadlines:
-
Pre-Application (Preproposal): June 30, 2025, 5:00 p.m. ET
-
Invitation to Submit Full Application: July 31, 2025
-
Full Application: October 1, 2025, 11:59 p.m. ET
-
End of Verification Period: October 7, 2025, 5:00 p.m. ET
Where to Go for Further Information & Application:
- Guidelines.
-
Grants.gov Workspace: search Funding Opportunity Number HT942525MRPIA
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023